Eledon Pharmaceuticals
Eledon Pharmaceuticals Logo
About Eledon Pharmaceuticals
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company specializing in the development of immunology-based therapies targeting the CD40L pathway. Its lead compound, tegoprubart, is an anti-CD40L antibody being developed to prevent organ transplant rejection and treat autoimmune and neurodegenerative diseases. Eledon is focused on advancing therapies for kidney, liver, and xenotransplantation, as well as conditions such as amyotrophic lateral sclerosis (ALS). The company leverages its expertise in immunomodulation to improve transplant outcomes and patient quality of life.
Address
19900 MacArthur Boulevard, Suite 550
Irvine, 92612
United States
Year founded
2004
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
